openPR Logo
Press release

The Global Immunosuppressant Drugs Market is set to Gain $14.18 Billion by the year 2028

08-03-2020 01:57 PM CET | Health & Medicine

Press release from: Triton Market Research

Global Immunosuppressant Drugs Market

Global Immunosuppressant Drugs Market

A report from Triton Market Research states that the global immunosuppressant drugs market, which accumulated $9.96 billion in 2019, will showcase 4.00% of CAGR by 2028.

A recent study by Triton Market Research titled ‘Global Immunosuppressant Drugs Market,’ covers the Global Analysis and Forecast for 2019-2028 by End-user (Autoimmune Disorders, Organ Transplantation, Others), by Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), Drug Class (mTOR Inhibitors, Calcineurin Inhibitors, Monoclonal Antibodies, Corticosteroids, Others), and by Geographical Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa).

Request Free Sample of the Global Immunosuppressant Drugs Market Report @ https://www.tritonmarketresearch.com/reports/immunosuppressant-drugs-market#request-free-sample

The report on the global immunosuppressant drugs market shows that the industry will garner $14.18 billion by the year 2028, expanding with a CAGR of 4.00% during the forecasting years from 2019 to 2028. Immunosuppressant drugs, also known as antirejection drugs, are agents that are used to mitigate or prevent the strength of the body’s immune system. They are given to organ transplant patients as well as those suffering from autoimmune disease.

Autoimmune diseases are characterized by attacks which can affect any part of the body, thereby weakening its functioning. This can even turn life-threatening. Factors such as evolution, environmental changes, and hormonal changes in women are responsible for the rise in cases of autoimmune disorders throughout the world. Therefore, there is a growing demand for immunosuppressive drugs from autoimmune disorder patients, which is driving the growth of the studied market.

However, the consumption of certain drugs can lead to different side-effects. These side-effects could prove fatal, thus limiting the life expectancy of transplant patients, when compared with the general population. This is majorly restricting the growth of the market.

The market for immunosuppressant drugs is mainly categorized into end-user, distribution channel, and drug class. Based on end-user, it is divided into autoimmune disorders, organ transplantation, and others. Whereas, based on distribution channel, it consists of online pharmacies, retail pharmacies, and hospital pharmacies. And on the basis of drug class, the market consists of mTOR inhibitors, calcineurin inhibitors, monoclonal antibodies, corticosteroids, and others.

Latin America is set to be the fastest-growing market, globally, over the forecasting period. Brazil and Mexico are the major contributors to the organ transplant market in the region. In Brazil, the number of potential and effective donors showed an impressive growth in the five-year period from 2013 to 2018. Whereas, in Mexico, there was a considerable rise in the number of heart, kidney, lung, pancreas, small bowel, and liver transplants, from 2010 to 2018. These rising cases of organ transplants have increased the demand for immunosuppressive drugs, thereby leading to the regional market growth over the forecast period.

F Hoffmann-La Roche Ltd, Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc), Mylan NV, Novartis AG, GlaxoSmithKline plc, Veloxis Pharmaceuticals Inc, Sanofi, Pfizer Inc, Intas Pharmaceuticals Ltd (Accord Healthcare), Astellas Pharma Inc, Allergan (acquired by Abbvie Inc), Abbvie Inc, Dr Reddys Laboratories Ltd, Cipla Ltd, and Bristol-Myers Squibb Company are some of the eminent players in the immunosuppressant drugs market.

Purchase this Report @ https://www.tritonmarketresearch.com/reports/immunosuppressant-drugs-market#purchase-option

Question & Answer: Immunosuppressant Drugs Market

Question 1: What is driving the growth of the immunosuppressant drugs market?
Answer: Autoimmune diseases are characterized by attacks which can affect any part of the body, thereby weakening its functioning. This can even turn life-threatening. Factors such as evolution, environmental changes, and hormonal changes in women are responsible for the rise in cases of autoimmune disorders throughout the world. Therefore, there is a growing demand for immunosuppressive drugs from autoimmune disorder patients, which is driving the growth of the studied market.

Question 2: What is restricting the growth of the market for immunosuppressant drugs?
Answer: consumption of certain drugs can lead to different side-effects. These side-effects could prove fatal, thus limiting the life expectancy of transplant patients, when compared with the general population. This is majorly restricting the growth of the market for immunosuppressant drugs.

Question 3: How is the Latin America region influencing the growth of the immunosuppressant drugs market?
Answer: Latin America is set to be the fastest-growing market, globally, over the forecasting period. Brazil and Mexico are the major contributors to the organ transplant market in the region. In Brazil, the number of potential and effective donors showed an impressive growth in the five-year period from 2013 to 2018.
Whereas, in Mexico, there was a considerable rise in the number of heart, kidney, lung, pancreas, small bowel, and liver transplants, from 2010 to 2018. These rising cases of organ transplants have increased the demand for immunosuppressive drugs, thereby leading to the regional market growth over the forecast period.

Question 4: Which are some of the eminent players in the immunosuppressant drugs market?
Answer: F Hoffmann-La Roche Ltd, Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc), Mylan NV, Novartis AG, GlaxoSmithKline plc, Veloxis Pharmaceuticals Inc, Sanofi, Pfizer Inc, Intas Pharmaceuticals Ltd (Accord Healthcare), Astellas Pharma Inc, Allergan (acquired by Abbvie Inc), Abbvie Inc, Dr Reddys Laboratories Ltd, Cipla Ltd, and Bristol-Myers Squibb Company are some of the eminent players in the immunosuppressant drugs market.

Related Report:
Global Hyperphosphatemia Market

The global hyperphosphatemia drugs market market has been forecasted to exhibit a CAGR of 16.61% during the projected years between 2019 and 2027, and generate a revenue of $11.48 billion by 2027.

Renal diseases affect people of all age groups. However, they are more prevalent in older people aged 60 years and above. In 2015, researchers at the Johns Hopkins University stated that more than half of the population above the age of 75 years is affected by renal diseases. Also, estimates from the WHO suggest that, by 2050, more than two billion people would be aged over 60. Kidney diseases lead to hyperphosphatemia, and thus, the growth in the geriatric population implies a growth in the hyperphosphatemia drugs market over the projected period.

Moreover, owing to the increasing aging populace, there has been a rise in the number of people suffering from conditions like osteoporosis. This growth in the number of osteoporosis patients, coupled with the changing dietary habits, is leading to the high accumulation of phosphorus in the body. This has led to cases of hyperphosphatemia, which has, in turn, increased the demand for drugs to cure this condition. The global market for hyperphosphatemia drugs is thus on a growth path.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Immunosuppressant Drugs Market is set to Gain $14.18 Billion by the year 2028 here

News-ID: 2101898 • Views: 215

More Releases from Triton Market Research

Use in Electronics Applications to Push the Global Carbon Nanotubes Market to Ga …
According to an analysis by Triton Market Research, the global carbon nanotubes market, which was valued at $5.20 billion in 2019, is anticipated to display a CAGR of 15.31% by 2028. A study by Triton Market Research with the title ‘Global Carbon Nanotubes Market,’ covers the Global Analysis and Forecast for 2019-2028 by Product Type (Single-Walled Carbon Nanotubes, Multi-Walled Carbon Nanotubes, Other Product Type), by Application (Fire Retardant Plastics, Conductive Adhesives,
Speedy Recovery Time to Push the Global Intragastric Balloon Market to Gain $103 …
As per a study by Triton, the global intragastric balloon market, which accounted for $36.22 million in the year 2019, is expected to showcase a CAGR of 12.33% by the year 2028. A study by Triton Market Research with the title ‘Global Intragastric Balloon Market,’ covers the Global Analysis and Forecast for 2019-2028 by Industry Verticals (Hospitals, Ambulatory Surgical Centers, Clinics), by Component (Single Balloon, Dual Balloon, Triple Balloon), by Filling
The Global Opioid Drugs Market to Garner $33.78 Billion by the year 2028
According to a Triton Market Research report, the global opioid drugs market accumulated $26.91 billion in 2019. And it is expected to showcase 2.56% of CAGR by 2028. A recent study by Triton Market Research titled 'Global Opioid Drugs Market,' covers the Global Analysis and Forecasts by Application (Anesthesia, Cough Suppression, De-addiction, Pain Relief, Diarrhea Suppression), by Product (Morphine, Hydrocodone, Fentanyl, Buprenorphine, Tramadol, Oxycodone, Other Products), and by Geography (North America,
Growing Construction Industry to Push the Global Carbon Black Market to Gain $16 …
According to an analysis by Triton Market Research, the global carbon black market, which was valued at $11.96 billion in the year 2019, is expected to display a CAGR of 3.36% by 2028. A study by Triton Market Research with the title ‘Global Carbon Black Market,’ covers the Global Analysis and Forecast for 2019-2028 by Application (Plastic, Tire & Industrial Rubber, Toner & Printing Ink, Textile Fiber, Paints & Coatings, Other

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Clomifene Citrate Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Clomifene Citrate Market" across the global, regional and country level. The report provides 360° analysis of "Clomifene Citrate Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Clomifene Citrate industry, and estimates the future trend of Clomifene Citrate market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business